Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain
Status:
Completed
Trial end date:
2019-10-31
Target enrollment:
Participant gender:
Summary
The study will be a prospective randomized double-blind placebo-controlled trial of
mirabegron for medical expulsive therapy (MET) in patients with a CT (Computed Tomography)
scan-proven ureteral stone between 4 to 10 mm undergoing expectant management.